Skip to content

This site is intended for US patients and caregivers.

Utility Navigation

Important Safety Information
Prescribing Information
Healthcare Professionals Site

Main Navigation

Cisplatin-induced Hearing Loss
What is PEDMARK?
- How is PEDMARK given?
- How does PEDMARK work?
Study Results
Safety
Fennec HEARS™
Helpful Tools

PEDMARK Dosing Guide

Posted on November 30, 2022 (November 30, 2022) by gmh-dev

Detailed guidance on appropriate dosing, preparation, pretreatment medication, timing, and administration of PEDMARK.

Post navigation

PEDMARK Patient Brochure

For US Patients and Caregivers Only

PEDMARK^® and Fennec^® are registered trademarks of Fennec Pharmaceuticals Inc.
Fennec HEARS™ is a trademark of Fennec Pharmaceuticals Inc.
©2025 Fennec Pharmaceuticals Inc. All rights reserved.
FEN-1447-v7 03/25

Contact Us
Privacy Policy
Cookie Policy
Terms & Conditions
Careers
Sitemap

The PEDMARK website is for US healthcare professionals only. Click "continue" only if you are a US healthcare professional.

You are now leaving PEDMARK.com.

Would you like to leave this site?